Delphi, a research group founded in 2012 at Carnegie Mellon University, focuses on advancing epidemic detection, tracking, and forecasting, using AI. Their flagship project, COVIDCast, which we collaborated on, aims to make epidemic forecasting as useful as weather forecasting.
Delphi is a leader in epidemic research, partnering with CDC, Google, Meta, and UnitedHealth Group/Optum. With an Epidata repository comprising over 500 real-time epidemic signals, they process more than 4 billion records, adding 3 million daily.
Some of Delphi’s notable achievements include:
- Multiple wins in CDC’s “Predict the Flu” challenge since 2014.
- Named a National Center of Excellence for Flu Forecasting (2019-2025).
- Recently designated a National Center for Innovation (2023-2028) by CDC.
Delphi’s primary mission is to make epidemic data widely accessible for public health agencies, the healthcare industry researchers, and the general public. To achieve this, they provide tools like the COVIDCast platform and the Signal Discovery App, which aggregates and filters multiple data sources. They develop ML and statistical models for nowcasting and forecasting infectious diseases. AI-powered anomaly detection algorithms identify unusual patterns or changes in epidemic signals, and trend detection models help public health agencies follow disease spread trajectories.